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Abstract: Dehydrolutein accumulates in substantial concentrations in the retina. The aim of this
study was to compare antioxidant properties of dehydrolutein with other retinal carotenoids, lutein,
and zeaxanthin, and their effects on ARPE-19 cells. The time-resolved detection of characteristic
singlet oxygen phosphorescence was used to compare the singlet oxygen quenching rate constants of
dehydrolutein, lutein, and zeaxanthin. The effects of these carotenoids on photosensitized oxidation
were tested in liposomes, where photo-oxidation was induced by light in the presence of photosensi-
tizers, and monitored by oximetry. To compare the uptake of dehydrolutein, lutein, and zeaxanthin,
ARPE-19 cells were incubated with carotenoids for up to 19 days, and carotenoid contents were
determined by spectrophotometry in cell extracts. To investigate the effects of carotenoids on photo-
cytotoxicity, cells were exposed to light in the presence of rose bengal or all-trans-retinal. The results
demonstrate that the rate constants for singlet oxygen quenching are 0.77 × 1010, 0.55 × 1010, and
1.23 × 1010 M−1s−1 for dehydrolutein, lutein, and zeaxanthin, respectively. Overall, dehydrolutein is
similar to lutein or zeaxanthin in the protection of lipids against photosensitized oxidation. ARPE-19
cells accumulate substantial amounts of both zeaxanthin and lutein, but no detectable amounts
of dehydrolutein. Cells pre-incubated with carotenoids are equally susceptible to photosensitized
damage as cells without carotenoids. Carotenoids provided to cells together with the extracellular
photosensitizers offer partial protection against photodamage. In conclusion, the antioxidant proper-
ties of dehydrolutein are similar to lutein and zeaxanthin. The mechanism responsible for its lack of
accumulation in ARPE-19 cells deserves further investigation.
Keywords: carotenoid; lutein; zexanthin; dehydrolutein; retina; retinal pigment epithelium; singlet
oxygen; photosensitized oxidation; age-related macular degeneration
1. Introduction
3′-Dehydrolutein, ((3R,6′R)-3-hydroxy- β,ε-caroten-3′-one also sometimes referred to
as 3′-oxolutein or 3′-ketolutein; Figure 1) has been identified in substantial concentrations
in human and monkey liver, blood serum, and ocular tissues [1–10]. It has been suggested
that dehydrolutein is a product of oxidative transformation of dietary carotenoids, lutein
(β, ε-carotene-3,3′-diol; Figure 1), and zeaxanthin (β, β -carotene-3,3′-diol; Figure 1). Out
of the approximately 40 carotenoids present in a typical human diet, lutein and zeax-
anthin are the only carotenoids of dietary origin that accumulate in the retina [11–15].
Antioxidant properties of lutein and zeaxanthin have been widely investigated, and it has
been well documented that they are very efficient quenchers of excited electronic states of
photosensitizers and singlet oxygen, and can act as scavengers of free radicals [15–17].
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of photosensitizers and singlet oxygen can occur [18–22]. Moreover, in the macular part 
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they can act as optical filters absorbing incoming blue light, thereby preventing blue light 
from reaching the parts of photoreceptive neurons and retinal pigment epithelium (RPE), 
where visual pigments are present and potent photosensitizers can accumulate [14,23–31]. 
Therefore, the macular carotenoids are credited with improving visual functions and pro-
tecting photosensitive parts of the retina from blue-light-induced oxidative damage. Al-
together, the antioxidant and blue-light filtering properties of lutein and zeaxanthin are 
believed to play an important role in protecting the retina against oxidative stress, and, 
therefore, in protecting from the development and progression of age-related macular de-
generation [15,16,32,33]. Macular degeneration is the primary cause of blindness in the 
elderly in developed countries. 
It has been determined that about 15% to 25% of retinal carotenoids are present in 
the photoreceptor outer segments, and, in smaller concentrations, in the RPE [34,35]. The 
photoreceptor outer segments are the parts of photoreceptive neurons where visual pig-
ments are present, and where, following absorption of light, all-trans-retinal can be re-
leased from photoactivated visual pigments and accumulate in high concentrations 
[21,34–36]. All-trans-retinal is a potent photosensitizer with an absorption spectrum that 
extends into the visible range. In the presence of oxygen, 30% of photons absorbed by all-
trans-retinal can be used for photosensitized generation of a singlet oxygen [20]. Therefore, 
the ability of lutein, zeaxanthin, and their derivatives to quench singlet oxygen deserves 
particular attention. Lutein and zeaxanthin each have the ability to deactivate singlet ox-
ygen with the bimolecular rate constants approaching the diffusion-controlled limits. The 
deactivation of the singlet oxygen excited states by carotenoids proceeds mainly via a safe 
route of energy transfer from the excited state of molecular oxygen to the carotenoid mol-
ecule, which is followed by thermal relaxation of the carotenoid triplet state to the ground 
state. This releases the excess energy in the form of heat [37]. 
Dehydrolutein is present in the human macula at substantial concentrations and in-
creases with age [1,3–5,8,10,38]. Post-mortem quantification of dehydrolutein in 4-mm di-
ameter trephine retinal biopsies centred on the maculae from cadavers < 48 years of age 
(average age of 32+/−8, n = 35) revealed 0.6+/−0.5 ng (0.048 ± 0.040 ng/mm2). In people > 48 
years of age (average age of 68+/−7, n = 38), it reaches a concentration of 1.3+/−1.8 ng in an 
identical retinal area (0.10 ± 0.14 ng/mm2), with the highest total value detected being 
about 12.5 ng [1,3,38]. Yet, the antioxidant properties of dehydrolutein and its effects on 
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The ability of lutein, zeaxanthin, and their derivatives to quench electronically excited
stat s is of physiological impor ance because these carotenoids accumulate in the areas
of the human body, such as the skin and eye, where, due to exposure to ultraviolet or
visible light in the pres nce of photosensitisers, generation of excited electronic states of
photosensitizers a d singlet oxygen can occur [18–22]. Moreover, in the macular part of
the retina, where lutein and zeaxanthin accumulate in particularly high concentrations,
they can ct as opti al filters absorbing incomin blue light, hereby preventing blue light
from reaching the parts of photoreceptive neurons and retinal pigment epithelium (RPE),
where visual p gments are presen and potent photos nsitizers can accumulate [14,23–31].
Therefore, the macular carotenoids are credited with improving visual functions and
pr t cting photosensitive parts of the retina from blue-light-induced oxidative damage.
Altogether, the anti xidant and blue-light filtering properties of lutein and zeaxanthin are
believed to play an important role in protecting the retina against oxidative stress, and,
therefore, in protecting from the development and progression of age-related macular
degeneration [15,16,32,33]. Macular degeneration is the primary cause of blindness in the
elderly in developed countries.
It has been determined that about 15% to 25% of retinal carotenoids are present in
the photoreceptor outer segments, and, in smaller concentrations, in the RPE [34,35]. The
photoreceptor outer segments are the parts of photoreceptive neurons where visual pig-
ments are present, and where, following absorption of light, all-trans-retinal can be released
from photoactivated visual pigments and accumulate in high concentrations [21,34–36].
All-trans-retinal is a potent photosensitizer with an absorption spectrum that extends into
the visible range. In the presence of oxygen, 30% of photons absorbed by all-trans-retinal
can be used for photosensitized generation of a singlet oxygen [20]. Therefore, the ability
of lutein, zeaxanthin, and their derivatives to quench singlet oxygen deserves particular
attention. Lutein and zeaxanthin each have the ability to deactivate singlet oxygen with the
bimolecular rate constants approaching the diffusion-controlled limits. The deactivation of
the singlet oxygen excited states by carotenoids proceeds mainly via a safe route of energy
transfer from the excited state of molecular oxygen to the carotenoid molecule, which is
followed by thermal relaxation of the carotenoid triplet state to the ground state. This
releases the excess energy in the form of heat [37].
Dehydrolutein is present in the human macula at substantial concentrations and
increases with age [1,3–5,8,10,38]. Post-mortem quantification of dehydrolutein in 4-mm
diameter trephine retinal biopsies centred on the maculae from cadavers < 48 years of
age (average age of 32+/−8, n = 35) revealed 0.6+/−0.5 ng (0.048 ± 0.040 ng/mm2). In
people > 48 years of age (average age of 68+/−7, n = 38), it reaches a concentration of
1.3+/−1.8 ng in an identical retinal area (0.10 ± 0.14 ng/mm2), with the highest total value
detected being about 12.5 ng [1,3,38]. Yet, the antioxidant properties of dehydrolutein and
its effects on cultured RPE cells have not been investigated. Therefore, the aim of this study
was to compare the abilities of dehydrolutein, lutein, and zeaxanthin to (i) quench singlet
oxygen, (ii) protect from photosensitized oxidation of lipids, and (iii) compare their effects
on RPE cells in the absence and presence of photosensitizers and light.
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2. Materials and Methods
2.1. General Chemicals and Reagents
Cholesterol, egg yolk phosphatidylcholine (EYPC), all-trans-retinal, 93-(4,5-dimethylth-
iazolyl-2)-2,5-diphenyltetrazolium bromide (MTT), butylated hydroxytoluene (BHT),
Chelex 100, and rose bengal (95%) were obtained from Sigma-Aldrich Chemical Co. De-
hydrolutein was synthesized as described previously [39]. Lutein (95% pure with 5% of
zeaxanthin) and zeaxanthin were a generous gift from DSM Nutritional Products AG
(Basel, Switzerland). The spin probe, 4-protio-3-carbamoyl-2,2,5,5-tetraperdeuteromethyl-
3-pyrroline-1-yloxy (mHCTPO), was a generous gift from Professor Howard Halpern,
University of Chicago, IL, USA. Unless stated otherwise, all procedures involving photo-
sensitizers and/or carotenoids were performed under dim light.
2.2. Determination of Singlet Oxygen Quenching by Dehydrolutein, Lutein, and Zeaxanthin
To determine the rate of singlet oxygen quenching, singlet oxygen was generated by
photoexcitation of all-trans-retinal solution in benzene with a 5-ns laser pulse of the third
harmonic of a Q-switched Nd:YAG laser (Continuum Surelite II-10, Photonic Solutions
Plc., Edinburgh, UK), and monitored by detecting its infrared emission at 1270 nm by
a liquid-nitrogen-cooled germanium diode (Applied Detectors Co., Fresno, CA, USA),
connected to an Agilent 54830B digitizer (Agilent Technologies UK Ltd., Cheadle, UK)
and analyzed by a RISC workstation operating the LKS.60 nanosecond time-resolved
laser photolysis spectrometer (Applied Photophysics, Leatherhead, UK) [19,20,40]. The
absorbance of 5.3 µM all-trans-retinal in a 1-cm square cuvette was about 0.17 at the
excitation wavelength of 355 nm for all the solutions. The rate constant for the quenching
of singlet oxygen by carotenoids was determined by quantifying the rate of decay of its
infrared phosphorescence in the presence of different carotenoid concentrations [18].
2.3. Preparation of Lipid Vesicles (Liposomes)
Multi-lamellar liposomes were prepared either from EYPC or a mixture of EYPC,
DMPC, and cholesterol in the presence and absence of all-trans-retinal or carotenoids [41,42].
The compounds were dissolved in chloroform in a round-bottom flask, and then the chlo-
roform was evaporated under a stream of argon to form a lipid film. To ensure a complete
removal of chloroform, the films were dried under vacuum for at least 1 h. Then the lipid
films were hydrated in phosphate buffered saline (PBS). PBS was prepared in deionized
glass distilled water and treated with chelating resin, Chelex 100, in order to remove any
contaminating metal ions that may catalyse the decomposition of peroxides. For experi-
ments with all-trans-retinal, carotenoids were added to the suspension of liposomes from
their stock solutions in DMSO, giving the final concentration of 1% DMSO and up to
0.04 mM carotenoids.
2.4. Comparison of the Effects of Dehydrolutein, Lutein, and Zeaxanthin on Photosensitized
Oxidation of Lipids
To determine the effect of carotenoids on photosensitized oxidation mediated by rose
bengal or all-trans-retinal, electron spin resonance (ESR) oximetry was used as described
previously [41,43,44]. In short, oxygen concentrations were monitored by spectral char-
acteristics of 0.1 mM mHCTPO employed as a nitroxide spin probe. The suspensions of
lipid vesicles in the presence of rose bengal or all-trans-retinal selected concentrations of
carotenoids, and 0.1 mM mHCTPO were irradiated in situ in a flat quartz cell (Wilmad
Glass. Co., Buena, NJ, USA) in a resonant cavity of the ESR spectrometer, at an ambi-
ent temperature using a 150 W xenon arc lamp (Oriel Corporation, Stratford, CT, USA;
06497 Model 60100) equipped with a combination of lenses and filters (a 5 g/L copper
sulphate solution with a 10-cm optical pathlength, a glass cut-off filter, and an interference
filter). For experiments with all-trans-retinal, a cut-off filter absorbing light < 390 nm, and
an interference filter transmitting light of 404 ± 6 nm was used. The irradiance inside the
resonant cavity, measured with a photodiode PD Irradiance Meter (Hamamatsu, Photonics,
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K.K., Hamamatsu City, Japan), was 8.1 mW/cm2. For experiments with rose bengal as
a photosensitizer, a cut-off filter absorbing light < 520 nm and an interference filter of
542 ± 4 nm were used. The irradiance of the sample was 14.0 mW/cm2. The temperature
variation was minimized by continuous flow of gaseous nitrogen through the resonant cav-
ity. ESR measurements were performed using the Bruker ESP 300E spectrometer operating
at the X band (Bruker, Rheinstetten, Germany). The instrument settings were: microwave
power of 1 mW, modulation amplitude of 0.1 G, sweep width of 3.0 G, time constant of
10.24 ms, and conversion time of 20.48 ms.
2.5. Cell Culture and Feeding with Carotenoids
ARPE-19 cells, which are a spontaneously “immortalized” and well-characterized
human retinal pigment epithelial cell line derived from a 19-year-old male donor, were
purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) [45].
ARPE-19 cells were routinely passaged by dissociation in 0.05% (w/v) trypsin, maintained
at 37 ◦C in a humidified incubator filled with 5% CO2 in air, and fed every two to three
days with minimal essential medium (MEM, Sigma-Aldrich Chemical Co., St Louis, MO,
USA), containing 10% heat-inactivated foetal calf serum (FCS), L-glutamine, and penicillin-
streptomycin (Sigma-Aldrich Chemical Co., St Louis, MO, USA). All experiments were
performed on confluent cell monolayers, passage numbers between 25 and 29, seeded
either in 75 or 25 cm2 flasks, or in 24-well or 12-well plates [19,46,47].
2.6. Administration of Carotenoids to Cultures of RPE Cells
Stock solutions of carotenoids were prepared under argon in DMSO under dim
light. To facilitate binding of carotenoids to serum lipoproteins and albumin, the carotenoid
solution was added to FCS and incubated for 1 h at 37 ◦C with mixing. Then, the carotenoid-
enriched FCS was added to the culture medium, giving a final concentration of 2 µM
carotenoids, 0.2% DMSO, and 10% FCS. Confluent monolayers of cells, starting usually
10 days after seeding, were fed with freshly prepared carotenoid-enriched culture medium
three times a week for up to 19 days.
Alternatively, carotenoids were injected directly into Dulbecco’s PBS with calcium
and magnesium (DPBS), and incubated with cultured cells for 60 min during exposure
to photosensitizers and light. After the incubation, cells were washed with DPBS, and
then DPBS was replaced with the culture medium for a further culture or the reductive
activity assay.
2.7. Evaluation of Carotenoid Content in Cells
To determine carotenoid uptake by ARPE-19 cells, the cells were trypsinized, 40 µL
aliquots were taken for cell counting, and the remaining cell suspensions were mixed
at a 5:8 ratio with chloroform/methanol (2:1, v/v) containing 1 mM BHT to prevent oxi-
dation [47]. The mixture was vortexed, and followed by centrifugation to separate the
phases. The bottom chloroform-rich phase was removed, replaced by a chloroform phase
obtained by centrifugation of a mixture of PBS with chloroform and methanol, and the
extraction was repeated. Combined chloroform phases were dried under nitrogen and
resolubilized in acetone or chloroform prior to spectrophotometric detection of the accu-
mulated carotenoids. The absorption spectra of solubilized extracts were measured in a
0.8-mL cuvette with a 1-cm optical pathlength.
2.8. Evaluation of Cell Viability
The morphology of the RPE monolayer was routinely observed using the inverted
microscope before the media changes and after experimental treatments. Cell viability
was quantified by measurements of their reductive activity by the MTT assay, and after
trypsinization by cell counts [19,46,47]. Cells were counted in a Bürker chamber. For the
MTT assay, cells were washed with DPBS, and then incubated for 60 min in serum-free
MEM containing 0.5 mg/mL MTT. Then, the cells were washed with DPBS and solubilized
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with isopropanol acidified with 0.5% HCl. Optical density of the solubilised formazan
was read at 570 nm. The reductive activities of cells exposed to carotenoids in the absence
of photosensitizers are expressed relative to DMSO-treated cells from the same plate and
given as a percentage. The reductive activities of cells exposed to DMSO/carotenoids in the
presence of photosensitizers are expressed as ratios to cells exposed to DMSO/carotenoids
in the absence of photosensitizers on the same plate, and given as a percentage.
2.9. Exposure of RPE Cells to Light and Photosensitizers
To test whether carotenoids can affect phototoxicity, ARPE-19 cells were washed from
the culture medium with DPBS, and the medium was replaced with DPBS containing
0.5 µM rose bengal or liposomes containing 0.5 mM all-trans-retinal and 2.8 mg/mL EYPC.
The 24-well plates with cells were placed on top of a glass sheet above the set of fluorescent
tubes, and cells were irradiated at 24–26 ◦C with white fluorescent light for 20, 30, 40, or
60 min. The irradiance, measured with IL2000 Spectrotube spectroradiometer (International
Light Inc., Newbury, MA, USA), was 0.46 mW/cm2. After selected irradiation times, the
cells were washed with PBS and fed with culture medium. The MTT assay was performed
immediately after exposure, or 24 h after exposure.
2.10. Subcellular Fractionation and Transmission Electron Microscopy (TEM)
The subcellular fractions from cells supplemented for 19 days with lutein or zeax-
anthin were isolated as described previously [20,44,48–52]. In short, confluent ARPE-19
monolayers were scraped from flasks (each with a surface area of 75 cm2). Cells from
six flasks for each carotenoid were combined and homogenized, which was followed by
centrifugation at 60 g for 7 min in PBS with 1 mM EDTA to remove nuclei and cell debris.
The pellet was subjected to another homogenization, while the supernatant was centrifuged
at 6000 g for 10 min. The pellets from 6000 g centrifugations were combined, resuspended
in 0.3 M sucrose, and layered on top of a discontinuous sucrose gradient consisting of 2.00,
1.80, 1.60, 1.55, 1.50, 1.40, 1.20, and 1.00 M sucrose. The samples were ultra-centrifuged
using L7 Beckman ultra-centrifuge for 1 h at 103,000 g. The fractions collected from each
sucrose density interface were diluted in 0.1M phosphate buffer at a pH of 7.2 and spun
down for 10 min at 6000 g. The resuspended pellets were divided into two equal portions:
one for carotenoid extraction and the other for TEM. All procedures were done on ice under
dim light, and centrifugations were done at 4 ◦C.
The processing of subcellular fractions for TEM was performed as described previ-
ously [53]. The pellets were resuspended in 2.5% glutaraldehyde in 0.1M phosphate buffer
at a pH of 7.2 at 4 ◦C, washed, solidified in 2% agar solution at 4 ◦C, postfixed in 1% OsO4,
dehydrated in graded series of ethanol and propylene oxide solutions, and embedded in
Epon 812. Ultrathin sections were cut on Tesla BS 490A ultramicrotome, double stained in
uranyl acetate and lead citrate, and examined with a Tesla BS-500 electron microscope.
2.11. Statistical Analysis
Unless stated otherwise, results are expressed as means ± SDs from at least three
independent experiments. Statistical analyses were performed using SigmaPlot14 and
one-way ANOVA, and were followed by all pairwise multiple comparison procedures
using Hol-Sidak method, where p < 0.05 was considered statistically significant.
3. Results
3.1. Singlet Oxygen Quenching
To compare the ability of dehydrolutein to that of lutein or zeaxanthin to quench
singlet oxygen, we used a 5-ns laser pulse excitation of all-trans-retinal to generate singlet
oxygen and monitored the rate of its decay in the absence and presence of increasing con-
centrations of dehydrolutein, lutein, or zeaxanthin (Figure 2A). For all three carotenoids, the
rates of singlet oxygen decay increased linearly with increasing carotenoid concentration
(Figure 2B). This allowed us to calculate the singlet oxygen quenching rate constants for
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each carotenoid. Our results demonstrated that lutein and zeaxanthin exhibited quenching
rate constants of (0.55 ± 0.02) × 1010 and (1.23 ± 0.02) × 1010 M−1s−1, respectively, which
are similar to the values reported in literature. Previously reported values for singlet oxy-
gen quenching in benzene are 1.2 × 1010 M−1s−1 and 0.66 × 1010 M−1s−1 for zeaxanthin
and lutein, respectively [37]. The rate constant of singlet oxygen quenching by dehydro-
lutein, (0.77 ± 0.02) × 1010 M−1s−1 was intermediate between the values for lutein and
zeaxanthin, demonstrating that dehydrolutein is also an effective singlet oxygen quencher.
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Figure 2. Dehydrolutein quenches singlet oxygen with a similar efficiency to that of lutein or
zeaxanthin. (A–C): Representative kinetics of formation and decay of singlet oxygen after a 5-ns
laser pulse photoexcitation of all-trans-retinal values in the absence and presence of dehydrolutein,
lutein, and zeaxanthin at indicated concentrations. Time 0 indicates when the sample was exposed
to the laser flash. The decays were fitted to exponential decay curves to obtain fitted parameters
corresponding to the rates of decay. (D): Rates of singlet oxygen decay plotted as a function of
carotenoid concentration. The quenching rate constants were determined by fitting straight lines to
obtain the fitted slopes, which correspond to the rates of quenching.
3.2. Effects of Dehydrolutein, Lutein, and Zeaxanthin on Photosensitized Oxidation
We have shown previously that zeaxanthin can inhibit lipid oxidation when incorpo-
rated into lipid vesicles (liposomes) and exposed to rose bengal and green light [41]. Here,
we used a similar model system to compare effects of dehydrolutein, lutein, and zeaxanthin
on rose-bengal-mediated oxidation (Figure 3). Liposomes containing unsaturated lipids
in the absence or presence of carotenoids were exposed to rose bengal and light to induce
photo-oxidation, which was monitored by measuring oxygen consumption. At 10 µM con-
centrations, all three carotenoids significantly decreased the rate of oxygen consumption.
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Zeaxanthin showed the greatest effectiveness in slowing down the initial rate of oxidation
by 47%, which was followed closely by dehydrolutein and which decreased the rate by
45%. However, that 2% difference was not statistically significant. Lutein at a concentration
of 10 µM was the least effective of the three carotenoids producing a decrease in the rate of
oxidation by 32%, and its effect was statistically different from that of both dehydrolutein
and zeaxanthin (p = 0.005 and 0.002, respectively). Increasing concentrations of carotenoids
to 20 µM brought about greater decreases in the rates of oxidation by 60%, 67%, and 69% for
lutein, dehydrolutein, and zeaxanthin, respectively, with no statistically significant differ-
ences between any of the carotenoids. At 40 µM concentrations, the carotenoids decreased
the initial rate of oxidation by 97% to 98%, and all three carotenoids were similarly effective.
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to lutein and zeaxanthin. (A) Representative kinetics of oxygen consumption during exposure to
rose bengal and green light of liposomes in the absence and presence of carotenoids at indicated
concentrations. Liposomes, consisting of 1 mg/mL egg yolk phosphatidylcholine (EYPC), 2.6 mM
cholesterol, 11.8 mM 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), and indicated concentra-
tion of carotenoids were exposed to green light (542 ± 4 nm, 14.0 mW/cm2) in the presence of 16-µM
rose bengal (RB). The samples included 0.1 mM, 4-protio-3-carbamoyl-2,2,5,5-tetraperdeuteromethyl-
3-pyrroline-1-yloxy (mHCTPO) used as a spin probe. The initial linear portions of the kinetics were
fitted to straight lines, and the slopes of these lines gave initial rates of oxygen consumption. (B) The
initial rates of oxygen consumption in the absence and presence of indicated carotenoids as a function
of carotenoid concentration. Statistically significant differences between the initial rates of oxygen
consumption in the presence of carotenoids used at the same concentration were only for 10 µM
lutein, which was significantly faster than for 10 µM dehydrolutein or zeaxanthin (p = 0.005 and
0.002, respectively).
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Rose Bengal is a water-soluble photosensitizer, which associates with the lipid mem-
brane, but does not penetrate through it [46]. Its photochemical properties are well-
characterized and its effects on cultured ARPE-19 cells have been previously tested [46]. It
is used in ophthalmic practice for diagnostic purposes on the surface of the eye and as a
potential agent for corneal photo-crosslinking. It does not penetrate inside the eye and has
no physiological effects on the retina [54]. To compare the effect of the three carotenoids on
photo-oxidation under more physiologically relevant conditions, we used all-trans-retinal,
which is a form of vitamin A that can reach high levels in the photosensitive structures
of the retina (Figure 4). As mentioned already, all-trans-retinal is a lipophilic photosen-
sitizer that absorbs ultraviolet, violet, and blue light and can accumulate in the retina
in photoreceptor outer segments during the normal physiological mechanism of retinal
light detection [21,36,49,55,56]. Under the experimental conditions used, in the absence of
carotenoids, all-trans-retinal and blue light induced a 6.5-fold faster oxygen consumption
than that induced by rose bengal and green light (Figures 2 and 3). All three carotenoids
exhibited effective photoprotection against photoxidation induced by all-trans-retinal and
blue light at 10 µM concentration (p < 0.001, in all three cases), decreasing the rate of
oxygen consumption by 30%, 34%, and 45%, respectively, for lutein, dehydrolutein, or
zeaxanthin. There was no significant difference between samples containing 10 µM lutein
and dehydrolutein. Zeaxanthin was more effective than either lutein or dehydroluten
(p < 0.001, in both cases) (Figure 4). At 20 µM concentration, lutein decreased the rate
of oxygen consumption by 68% and was less effective than dehydrolutein or zeaxanthin
(p < 0.001, in both cases), which decreased the rates by 72% and 75%, respectively. There
was no significant difference in protection offered by either dehydrolutein or zeaxanthin at
this concentration. At 40 µM concentration, the carotenoids decreased the rates of oxygen
consumption from 88% to 92% and there were no significant differences between any of
the carotenoids.
Altogether, the differences between these carotenoid abilities to slow down photooxi-
dation could be seen only at a concentration of 10 µM. Dehydrolutein was more effective
than lutein, and similar to zeaxanthin, in protection of lipids from photosensitized oxida-
tion mediated by rose bengal. Protection against all-trans-retinal-induced photooxidation
by dehydrolutein or lutein was similar, while zeaxanthin was slightly more effective. At
20 and 40 µM concentrations, all three carotenoids were equally effective in protection from
photooxidation.
3.3. Effects of Supplementation with Dehydrolutein, Lutein, and Zeaxanthin on Carotenoid
Content in Cultured Retinal Pigment Epithelial Cells ARPE-19
ARPE-19 cells are a spontaneously immortalized cell line derived from retinal pigment
epithelium of the 19-year-old male donor, and were used in passage numbers where these
cells retain their retinal pigment epithelial cell characteristics [45]. Importantly, these cells
express receptors, such as a class B scavenger receptor type 1 (SR-BI) and low-density
lipoprotein (LDL) receptor, which have been demonstrated to be involved in carotenoid
uptake [57–60]. To compare the effects of dehydrolutein with those of lutein and zeaxanthin
in cultured ARPE-19 cells, the confluent cells were incubated for up to 19 days with 2 µM
carotenoids solubilized first in foetal calf serum (FCS) and then in the culture medium to
mimic physiological conditions where carotenoids are carried in the blood plasma mostly
bound to lipoproteins. The concentration of carotenoids was chosen based on the highest
values of lutein and zeaxanthin in human serum reported in the literature. At the time
when lutein and zeaxanthin supplements were not available, it was determined, in a large
cohort of 8229 persons above the age of 40 years of various ethnic backgrounds, that the
average combined concentration of lutein and zeaxanthin in human serum in people with
the highest values was 0.79 µM [61]. It was shown later that, by supplementation, these
values can be increased to about 2 µM [12,62,63].
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At selected days, cells were trypsinized, 40-µL aliquots were taken for determining
cell concentration, and the remaining suspension was used for extracting carotenoids
and quantifying by spectrophotometry (Figure 5). Feeding cells with zeaxanthin resulted
in a monotonic, almost linear, increase in concentration of cellular zeaxanthin, reaching
concentrations of about 1.1 nmol/million cells after eight feedings provided over 19 days
(Figure 5). Lutein uptake was less efficient and appeared to reach a plateau after six
feedings, and a cellular content of about 0.7 nmol/million cells after 19 days. Based on
these data, the average concentrations in cells can be estimated. Assuming the height of the
cell monolayer is 8 µm and the surface area of the cell culture flask is 25 cm2, the 4.2 million
cells occupied a volume of 0.02 mL, giving the average concentration of 0.23 and 0.15 mM
for zeaxanthin and lutein, respectively. This means that cells accumulated 116-fold and
74-fold greater concentrations of carotenoids than those provided in the culture medium.
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This is consistent with previous studies, albeit with a much shorter supplementation time,
showing that ARPE-19 cells accumulate lutein and zeaxanthin and can achieve intracellular
concentrations exceeding the concentration of these carotenoids in the culture medium by
several-fold [59,64]. In contrast, cells fed with dehydrolutein accumulated very little, if
any, of this carotenoid (Figure 5). It has been suggested that any dehydrolutein formed in
the retina by oxidation of lutein may be reduced to regenerate lutein or epi-lutein [3]. A
reduction of keto carotenoid canthanxanthin to its corresponding mono derivatives and diol
derivatives has been documented in the primate retina [65]. However, we did not observe
accumulation of any carotenoids in cells fed with dehydrolutein. These results indicate a
highly selective uptake and accumulation of lutein and zeaxanthin, and a surprising ability
of RPE cells to either exclude or efficiently excrete absorbed dehydrolutein.
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f ti ith ehydrolutein, Lutein, and Zeaxanthin on Viability of
-19 ells
I portantly, the supple entation with carotenoids did not affect cell numbers in the
confluent cultures. The cell nu bers re ained si ilar over the entire period of supple-
mentation in the flasks fed with different types of carotenoids, similar to cell numbers
in the flasks treated with DMSO only, and similar to cell numbers per flask prior the
supplementation treatment (Figure 6A). The reductive activities of carotenoid-containing
cells were significantly reduced in comparison with cells fed with dehydrolutein or DMSO
(Figure 6B). The reductive activity of cells fed with lutein or zeaxanthin, measured by the
MTT assay, were 18% and 19% smaller, respectively, than reductive activities of cells supple-
mented with DMSO only (p < 0.001 in both cases). Cells fed dehydrolutein had a decreased
reductive activity that was 8% lower than cells fed with DMSO, but that difference was not
statistically significant (p = 0.075).
The 1 h of exposure for ARPE-19 cells to Dulbecco’s phosphate buffered saline (PBS),
in the presence or absence of visible light, upregulated the reductive activities of cells
fed lutein or zeaxanthin. As a result, the values were similar for all three carotenoids
(Figure 6C,D), suggesting that deprivation of glucose and other nutrients present in the
normal growth media can upregulate the reductive activity once they are available again.
Twenty-four hours post-exposure to Dulbecco’s PBS with and without light, the reductive
activities of lutein-containing or zeaxanthin-containing cells returned to the values similar
to those observed without any pre-treatment in PBS (Figure 6B,E,F). It has been shown
previously on canine lens epithelial cells that lutein can decrease their reductive activities
measured by the MTT assay [66]. The reductive activity assay measured by MTT reflects
mainly the activity of glycolytic enzymes and NAD(P)H production [67]. It has been
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shown that lutein can decrease activities of several reductive enzymes, such as aldose
reductase, sorbitol dehydrogenase, and isocitrate dehydrogenase [68,69], and that lutein
and zeaxanthin can decrease the rate of oxidative phosphorylation [70–74]. However, there
are also reports demonstrating that lutein can increase glycolysis and upregulate oxidative
phosphorylation [75]. Since the presence of carotenoids affected the reductive activities of
cells, the reductive activities of cells exposed to photosensitizers and light were calculated
as a ratio of reductive activity of cells exposed to light in the presence of the photosensitizer
to reductive activity of cells in the absence of the photosensitizer, but subjected to the same
treatment with respect to carotenoids and light.
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Figure 6. Supplementation with carotenoids does not affect cell viability but dehydrolutein can
decrease their reductive activities. (A): RPE-19 cell density before and after feeding with carotenoids
for up to 19 days. The symbols represent means, while the error bars represent SDs. (B): Reductive
activities of cells after 19 days of supplementation with vehicle (DMSO) or carotenoids: dehydrolutein
(DHLut), lutein (LUT), and zeaxanthin (ZEA) measured by the MTT assay. (C,D): Reductive activities
of cells after 19 days of supplementation with vehicle (DMSO) or indicated carotenoids measured
by MTT assay after 1 h incubation in Dulbecco’s phosphate buffered saline (PBS) in dark (C) or
with concomitant exposure to white light (D). (E,F): Reductive activities of cells after 19 days of
supplementation with vehicle (DMSO) or indicated carotenoids measured by MTT assay 24 h after
1 h incubation in PBS in dark (E) or with exposure to white light (F). (B–F): the symbols correspond
to individual m asurements, the heights of the bars correspond to the means, and the error bars
correspond to SDs.
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3.5. Effects of Supplementation with Dehydrolutein, Lutein, and Zeaxanthin on Susceptibility of
ARPE-19 Cells to Photosensitized Damage
Similar to a previous report [46], exposure to green light in the presence of rose
bengal induced a rapid damage to ARPE-19 cells, resulting in an immediate decrease in
their reductive activity (and viability) when measured immediately after 1 h of exposure
(Figure 7A). The reductive activity in cells treated with DMSO without carotenoids and
exposed for 20, 40, and 60 min to rose bengal and light decreased by 21%, 61%, and 76%,
respectively, in comparison to cells exposed to light in the absence of rose bengal. The
reductive activities of cells fed for 19 days with lutein, zeaxanthin, or dehydrolutein and
then exposed to rose bengal and light were similar to those in cells without carotenoids
(Figure 6A).
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Figure 7. Supplementation with carotenoids for 19 days does not affect reductive activity of cells following damage induced
by photosensitizers and light. Reductive activities of cells after 19 days of supplementation with vehicle (DMSO) or
carotenoids: dehydrolutein (DHLut), lutein (LUT), and zeaxanthin (ZEA) measured by MTT assay immediately after 20, 40,
or 60 min exposure to visible light (0.46 mW/cm2) and 0.5 µM rose bengal (A) or 24 h after 30 or 60 min exposure to visible
light and liposomes containing 0.5 mM all-trans-retinal and 2.8 mg/mL EYPC (B). The reductive activities are expressed as
ratios of reductive activity of cells in the presence of the photosensitizer to reductive activity of cells exposed to the same
treatment in the absence of the photosensitizer. The symbols indicate individual measurements, the heights of the bars
indicate the means, and the error bars indicate SDs. There were no statistically significant differences between DMSO and
carotenoid-supplemented cells under each duration of exposure to light and rose bengal or all-trans-retinal.
Unlike phototoxicity of rose bengal, which causes immediate loss of cell viability [46],
all-trans-retinal phototoxicity takes longer to affect cell viability [19], and, therefore, the
reductive activities were measured 24 h after the exposure. The reductive activities of cells
exposed to all-trans-retinal and light were decreased in comparison to cells without all-trans-
retinal by about 32% and 78% for 30-min and 60-min exposures, respectively (Figure 7B).
Responses of cells that were supplemented with lutein, zeaxanthin, dehydrolutein, or
DMSO only were not significantly different from each other. The carotenoids accumulated
over 19 days of feeding did not make cells more resistant to photosensitized killing by either
rose bengal or all-trans-retinal when compared to cells without carotenoids (Figure 7A,B).
It appears that incorporation of lutein and zeaxanthin into cells makes them ineffective in
protecting the cells from photosensitizers, which generate their reactive oxygen external to
the plasma membranes.
This may suggest that the massive accumulation of lutein and zeaxanthin occurs in
intracellular organelles. Following endocytosis of lutein and zeaxanthin, it can be expected
that these carotenoids enter an endo-lysosomal compartment. To determine whether or
not lutein and zeaxanthin accumulate in ARPE-19 cell endosomes/lysosomes, the cells
were cultured in 75-cm2 flasks and supplemented with lutein and zeaxanthin for 19 days.
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For each carotenoid, cells were cultured in six flasks to give a similar surface area of the
RPE monolayer as RPE-occupying hemispheres of 40 human eyes we used for subcellu-
lar fractionation in our previous studies [44,48–52]. To investigate the localization in the
ARPE-19 cell, we performed subcellular fractionation using differential centrifugation.
Most lutein and zeaxanthin were lost in the pellet from low-speed centrifugation and/or in
the supernatant from pelleting the post-nuclear fraction. The post-nuclear fraction was sep-
arated by ultracentrifugation on a discontinuous sucrose gradient. Lutein and zeaxanthin
were detectable at interfaces at several sucrose densities starting at 0.25/1.0 M down to
1.4 M (Figure 8A). Examination of these bands by transmission electron microscopy (TEM)
revealed that these fractions were rich mostly in endosomes, lysosomes, phagolysosomes,
and some mitochondria (Figure 8B–E).
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To determine whether carotenoids can protect the cells against photodamage while
localised extracellularly, cells pre-treated with carotenoids for 19 days were exposed to
rose bengal and light in the presence of 2-µM carotenoids and 0.2% DMSO solubilized
directly in Dulbecco’s PBS (Figure 9A). This treatment resulted in a significant protection
by carotenoids at all exposure times. In case of a 20-min exposure to light and rose bengal,
the reductive activity for DMSO-treated cells was 77%, whereas, for cells treated with
dehydrolutein, lutein, and zeaxanthin, these activities were significantly higher: 95%, 92%,
and 90%, respectively. The 40-min exposure to light and rose bengal resulted in a reductive
activity of 43% in DMSO-treated cells, and 64%, 67%, and 66% for dehydrolutein, lutein,
and zeaxanthin-treated cells. In addition, for the 60-min exposure, the reductive activities
for carotenoid-treated cells were statistically greater than for DMSO-treated cells: 25% in
DMSO-treated cells, and 40%, 41%, and 38% for cells supplemented with dehydrolutein,
lutein, or zeaxanthin, respectively. This approach also proved effective in protecting against
photodamage induced by all-trans-retinal and light, where carotenoids increased reductive
activities from 25% in DMSO-only-treated cells to about 36%, 34%, and 33%, respectively,
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for cells supplemented with lutein, zeaxanthin, or dehydrolutein and exposed to the
retinoid and light for 60 min (Figure 9B). For cells exposed to all-trans-retinal and light
for 30 min, the increase was from 67% in DMSO-treated cells to 87%, 88%, and 86% for
cells treated with dehydrolutein, lutein, or zeaxanthin, respectively. While the p values
were smaller than 0.001 for differences between DMSO and a carotenoid treatment for
each exposure type, there were no statistically significant differences between any of the
three carotenoids.
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with vehicle (DMSO) or carotenoids: dehydrolutein (DHLut), lutein (LUT), and zeaxanthin (ZEA)
measured by MTT assay immediately after 20, 40, or 60 min of exposure to visible light and 0.5 µM
rose bengal (A) or 24 h after 30 or 60 min of exposure to visible light and liposomes containing
0.5 mM all-trans-retinal and 2.8 mg/mL EYPC (B). The exposure to photosensitizers and light was in
the presence of 0.2% DMSO and 2 µM carotenoids solubilized in DPBS. (C,D): Reductive activities
of cells without prior feeding with carotenoids, which were exposed to light, photosensitizers, and
carotenoids. The MTT assay was performed immediately after the exposure to light and 0.5 µM rose
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indicate individual measurements, the heights of the bars indicate means, and the error bars indicate
SDs. Treatments with carotenoids resulted in a statistically significant increase in the reductive
activities in comparison with DMSO-only-treated cells in all types of experiments (p < 0.001). The
differences between the effects of different carotenoids in the same type of exposure were not
statistically significant.
There are numerous reports showing that lutein and/or zeaxanthin can modulate
expression of several antioxidant enzymes, and can activate the nuclear factor erythroid
2-related factor 2 (Nrf2) signalling responsible for the expression of antioxidant response
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element (ARE) genes, and, subsequently, the synthesis of antioxidant and detoxification
proteins [68,69,76–89]. It has been reported that DMSO can activate Nrf2 [90]. Therefore,
we considered a possibility that long-term feeding with carotenoids/DMSO may affect
cellular responses to oxidative stress induced by the exposure to light and photosensitizers,
and used ARPE-19 cells without the long-term feeding with carotenoids while exposing
them to photosensitizers and light with DMSO/carotenoids provided at the same time
(Figure 9C,D). Under these conditions, the reductive activities were similar as in cells
supplemented with carotenoids for 19 days and then exposed to photosensitizers and
carotenoids solubilized in PBS (compare Figure 9A with Figure 9C, and Figure 9B with
Figure 9D). For the 60-min exposures, the reductive activities increased from about 22% in
cells treated with DMSO to 42%, 43%, or 42% for cells exposed to light and rose bengal,
and from 20% to 36%, 35%, and 32% for cells exposed to light and all-trans-retinal in the
presence of dehydrolutein, lutein, or zeaxanthin, respectively (Figure 9C,D). Again, there
were no significant differences in protection offered by the three carotenoids under the
same exposure conditions in any of these cases.
The protection offered by the short-term treatment with carotenoids was similar in
cells with and without long-term carotenoid supplementation (Figure 9A–D). Therefore, it
appears that the accumulation of carotenoids inside cells does not affect cellular responses
to the photo-oxidative damage induced by extracellular photosensitizers and light.
4. Discussion
Altogether, our results demonstrate that antioxidant properties of dehydrolutein are
similar to those of lutein and zeaxanthin. All three carotenoids are effective singlet oxygen
quenchers, which can slow down the photo-oxidation of lipids mediated by photo-excited
rose bengal or all-trans-retinal. This is important because at least some zeaxanthin and
lutein in the retina appear to be bound with high selectivity and specificity to glutathione
S-transferase Pi isoform (GSTP1) and steroidogenic acute regulatory domain protein 3
(StARD3) proteins, respectively [8,91–95], which would limit their diffusion rates [96]
and, consequently, their efficiency as singlet oxygen quenchers. On the other hand, to
date, no dehydrolutein-binding protein has been identified. Lacking a specific binding
protein, dehydrolutein may be more likely to be present in the lipid membranes as a
free carotenoid, and, thereby, may be more physiologically effective as a singlet oxygen
quencher protecting components of the lipid membrane from photosensitised oxidation.
Therefore, the localization of dehydrolutein in the retina deserves further investigation
to determine: (i) in which retinal layers, (ii) in which cell types and their subcellular
compartments it is present, and (iii) whether it is present as a free carotenoid in lipid
membranes or it is bound to proteins.
These are challenging tasks because it is still unknown in which subcellular com-
partment lutein and zeaxanthin accumulate, and whether they accumulate in the same
compartment or in different compartments. What is well documented is that lutein and
zeaxanthin accumulate in the retina in different areas as a function of eccentricity from
the fovea centre, with zeaxanthin being highly concentrated in the fovea while lutein
being distributed more diffusely across the retina [24,97,98]. It has been determined using
confocal resonance Raman microscopy that the zeaxanthin:lutein ratio can be greater than
9:1 in the centre of the fovea, decreases to 4:1 200 µm from the centre, and an additional
200 µm away, the ratio becomes 1:4 [24]. In the peripheral retina, >5 mm from the foveal
center, the total concentration of zeaxanthin+lutein is approximately 1/100 that of the
central fovea [99]. Across the retinal layers in the fovea, the greatest concentrations of
each, zeaxanthin and lutein, are in the Henle’s fibre layer and are clearly visible in mi-
crosections [100]. The Henle’s fibre layer contains axons of foveal photoreceptors and
these carotenoids are also present in high concentrations where the Henle’s fibre layer
transitions into the outer plexiform layer and where axonal terminals of photoreceptors
make synaptic connections with bipolar and horizontal cells. Lutein and zeaxanthin also
reach high density in the inner nuclear layer with cell bodies of glial Müller cells and three
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types of neurons: bipolar, horizontal, and amacrine cells in the inner plexiform layer with
synaptic connections between bipolar cells with amacrine and a retinal ganglion cell, and
in the outer nuclear layer with cell bodies of photoreceptors. The Müller cell processes
are spread across all these layers and there is a growing body of evidence that macular
carotenoids can be bound to these glial cells (reviewed by Curcio [101]).
It has been demonstrated that the majority of lutein and zeaxanthin in the macula is
highly organized and concentrically aligned relative to the central axis, passing through
the pupil and the macula, i.e., the visual axis [102]. Such an organizational feature of
the macular pigment is the accepted explanation of the entoptical phenomenon, which
is known as Haidinger’s brushes. Haidinger’s brushes can be seen as an hour-glass
shaped darkening when a horizontally plane-polarized short wavelength (blue) light
passes through the retina at the center of the visual field and is attributed to the preference
of the concentrically arrayed pigment molecules laying above and below the axis to absorb
the horizontal polarized light whereas molecules laying either to the left or right of the axis
do not. This hour-glass entopical figure rotates with the plane of the polarized light, always
being oriented at 90◦ to the plane of polarization, and has an action spectrum identical
to the absorption spectra of the carotenoids, lutein and zeaxanthin, which compose the
macular pigment [102]. The arrangement of lutein and zeaxanthin arises because Henle’s
fibres extend radially from the center of the fovea outward to the peripheral retina and
the carotenoids are either incorporated by spanning the bilayer lipid membrane or are
associated with proteins that are axially arrayed along the axon length, which results in a
similar organizational arrangement of the carotenoids.
It has been shown that carotenoids can bind to several proteins [29]. They include
tubulin, which is abundant in axons, but the binding is of low specificity and affinity. In
addition, the interphotoreceptor retinoid binding protein (IRBP), which is present in the
space around inner and outer segments of photoreceptors, binds both lutein and zeaxanthin
with low specificity, but the affinity is high, which is similar to that of retinoids [103]. These
are constituents of all species and are not the primary candidates responsible for the binding
of carotenoids of the macular pigment, a feature that is anatomically unique to the primate
retina. In addition to those mentioned above, there are other proteins in the primate retina
that bind to carotenoids with high specificity and affinity: steroidogenic acute regulatory
domain 3 (StARD3) and a pi isoform of glutathione S-transferase (GSTP1), which bind to
lutein and zeaxanthin, respectively [29].
GSTP1 is considered to be a cytosolic enzyme whereas the majority of the lutein
and zeaxanthin in the retina are membrane-associated and require detergent to solubilize
them [34,92]. However, it cannot be excluded that GSTP1 undergoes post-translational
modification, which anchors it in the lipid membrane. It has been reported that the
immunofluorescence of the antibody to human recombinant GSTP1 appears throughout all
retinal layers in the human macula, including inner and outer segments of photoreceptors,
with the greatest expression in the inner and outer plexiform layers, where retinal neurons
make synaptic junctions [92]. It appears absent in the nuclei of retinal cells. In another
report, the strongest labelling in the monkey macula appears along the outer limiting
membrane with some cone inner segments stained heavily while others are not stained at
all [29]. It has been proposed that GSTP1 can bind zeaxanthin at the carotenoid to protein
stoichiometry of 2:1 [92]. It has been pointed out that GSTP1 is a small, 24 kDa globular
protein. Therefore, binding a long planar ligand, such as zeaxanthin, could expose a large
portion of that lipophilic ligand to the external environment [104].
StARD3 was detected by Western blotting in the human neural retina and RPE-
choroid, and its mRNA expression was confirmed by RT-PCR in the human retina [95].
Immunocytochemistry on the monkey retina demonstrated StARD3 antibody binding
in retinal layers spanning from the ganglion cell layer to the outer limiting membrane
with the greatest density in the Henle’s fibre layer [29,95]. In addition, RPE was heavily
stained but that staining was non-specific to the StARD3 antibody. The retinal layers
of the outer segments of photoreceptors containing membraneous discs packed with
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visual pigments, and inner segments of photoreceptors with mitochondria, endoplasmic
reticulum, and Golgi apparatus, as well as the interphotoreceptor matrix filling the space
between photoreceptors exhibited relatively low staining intensity [95]. Co-labelling of
cone photoreceptors showed that the StARD3 antibody labels cones with greater intensity
than rods. However, the labelling on cones was rather patchy with only some areas
showing co-labelling. The co-labelling of Müller cells showed no co-localization of the
StARD3 antibody with Müller cells.
It has been demonstrated that optical density of the macular pigments can be increased
by supplementation with lutein over a period of 140 days [105]. Once the supplementation
was stopped, the increase in macular pigment density continued for another 43 days and
reached a stable level, which remained the same for the following 150–200 days. Afterward,
monitoring was stopped. The long-term stability of the macular pigment in the retina
over this period after discontinuation of supplementation is remarkable, considering the
environment in the retina, which is exposed daily to high fluxes of light in the presence of
various photosensitizers and high abundance of polyunsaturated lipids. Carotenoids are
rather labile compounds susceptible to oxidative degradation. Therefore, their stability in
the macula also suggest that they are protected from oxidation and degradation by proteins
and/or sequestered in other immobilizing structures.
It remains an open question which subcellular compartments accumulate lutein and
zeaxanthin, and whether or not they accumulate in the same structures, i.e., cytoplasm,
vesicles, membranes, or subcellular protein framework even though, as noted earlier,
evidence supports cell lipid bilayers or other radially arrayed structures within the retina.
The massive accumulation of lutein and zeaxanthin in cultured ARPE-19 cells prompted us
to investigate their localization in these cells using differential centrifugation to quantify
carotenoids in subcellular fractions. Lutein and zeaxanthin were detected at interfaces
at several sucrose densities starting at 0.25/1.0 M down to 1.4 M. Examination of these
bands by transmission electron microscopy revealed that these fractions were rich mostly in
endosomes, lysosomes, phagolysosomes, and some infrequent mitochondria. This suggests
that lutein and zeaxanthin may co-localize in phagocytosed tips of photoreceptor outer
segments and offer their protection from singlet oxygen generated due to photo-excitation
of all-trans-retinal, oxidized polyunsaturated lipids and/or lipofuscin [19–21,44,106,107].
Our results also demonstrate that, while the long-term exposure of ARPE-19 cells
to dehydrolutein, lutein, or zeaxanthin leads to a substantial accumulation of lutein and
zeaxanthin within the cells, the dehydrolutein does not accumulate to a significant extent.
This interesting observation suggests that ARPE-19 cells possess a selective uptake mech-
anism for lutein and zeaxanthin but can exclude dehydrolutein. Alternatively, there is
an efficient mechanism of dehydrolutein removal following uptake. It has been shown
that ARPE-19 cells can take up lutein and zeaxanthin from human serum, and the uptake
is more efficient for these carotenoids when zeaxanthin is bound to HDLs than to LDLs,
and when lutein is bound to LDLs than to HDLs [59]. In the human retina, similar to
the results shown here, the selective accumulation occurs. Of approximately 14 dietary
carotenoids present in blood serum [91], only two accumulate in the retina [11–15]. The
RPE, together with endothelial cells of retinal capillaries, provides the blood-retina barrier,
and, therefore, it is involved in the selective uptake of carotenoids and their transepithelial
transport [58]. However, the mechanisms responsible for that selectivity and transepithelial
transport into the retina are still poorly understood. Further investigations of dehydro-
lutein interactions with ARPE-19 cells may be helpful as a model to investigate these
transport mechanisms and determine if the presence of dehydrolutein in the retina is a
result of its uptake from the blood via transepithelial transport or a result of converting
of lutein/zeaxanthin inside the retina. It has been shown by Thomas and colleagues that
β-carotene-9′,10′-dioxygenase (BCO2), which catabolizes various carotenoids and apo-
carotenoids, can convert dehydrolutein into apocarotenoids [108]. It has been reported that
ARPE-19 cells express this enzyme using qRT-PCR and Western blotting. Exposure to lutein
further increases BCO2 mRNA [109]. The experimental difficulty is that the commercial
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antibody used to detect BCO2 in the human and mouse retinas by Li and colleagues [110]
was shown later to be non-specific to BCO2 and labelled something else in both bcdo2+/+
and bcdo2-/- mice [108]. There is a possibility that could be tested on ARPE-19 cells that
lutein and zeaxanthin can avoid enzymatic degradation by binding to proteins whereas
dehydrolutein remains unbound and is an available substrate for BCO2. Another path-
way by which ARPE-19 cells could remove dehydrolutein is by incorporating them into
lipoproteins that they synthesize and secrete. Such a scenario is supported by experiments
showing that carotenoid-containing lipoproteins can be synthesized and secreted by CaCo-
2 cells [57,111]. Curcio and colleagues demonstrated RPE cells can synthesize and secrete
lipoproteins [101,112], while Amin et al. [113] demonstrated that ARPE-19 cells can secrete
membranous sub-RPE deposits when supplemented with a retinal extract.
We have shown that cells with accumulated lutein and zeaxanthin exhibit a small
decrease in the reductive activity toward MTT. The decrease is reversible. After depriving
cells from nutrients present in the culture medium for an hour, the reductive activity
increases to levels similar to cells without accumulated carotenoids once the glucose and
other nutrients became available. The MTT assay is widely used as a measure of cell
viability. However, it measures the reduction of MTT to formazan, which can be affected by
an activity of various enzymes and availability of NAD(P)H [67]. It was demonstrated that
the MTT reductive activity is not affected, or, in some cases, even enhanced (by sparing
NADH), by inhibitors of a mitochondrial electron transport chain, but it decreases in the
presence of inhibitors of glucose uptake and cytoplasmic glycolysis [114]. Therefore, it has
been suggested that MTT reduction can be viewed as a measure of the glycolytic activity
and NAD(P)H production [114]. It has been shown that lutein supplementation can affect
activities of several enzymes in the heart and kidney of a rat model with diabetes [68],
can modulate expression of a number of genes in murine liver [69], and, in ARPE-19
cells, activates the transcription factor Nrf2, which, in turn, activates genes encoding
antioxidative and phase II enzymes that are involved in the maintenance of the cellular
redox status as well as in the detoxification of xenobiotics, including NAD(P)H:quinone
oxidase, NQO1 [85]. Thus, the decreased reductive activity in the presence of lutein and
zeaxanthin may reflect their effects on NAD(P)H and glycolysis. In addition to the MTT
assay, we used cell counting as a measure of cell viability. The cell numbers remained
similar to the initial ones throughout the duration of the 19-day supplementation. Therefore,
we concluded that lutein, zeaxanthin, and dehydrolutein do not affect the cell viability.
Despite accumulation of substantial amounts of lutein and zeaxanthin, none of these
carotenoids protects ARPE-19 cells from photo-oxidative damage caused by photosensitiz-
ers, which are present externally to the cells—either as water soluble, cell-impermeable
rose bengal or lipophyllic all-trans-retinal incorporated into lipid vesicles. Based on the
lack of protective effects of carotenoids supplemented over a period of 19 days against
photo-oxidative damage induced by photosensitizers not penetrating through the plasma
membrane, it can be suggested that lutein and zeaxanthin accumulate either inside the cell
and/or are bound within the plasma membrane, preventing their action as singlet oxy-
gen quenchers. Partial protection from photo-oxidative damage induced by extracellular
photosensitizers is achieved by all three carotenoids, with each having similar efficiency,
but only when they are present extracellularly together with the photosensitizers. Upon
injection into PBS of carotenoids solubilized in DMSO, the carotenoids largely precipitate.
At least some of the precipitates will likely accumulate in the plasma membrane where it
can get re-solubilized. The protective effect of carotenoids administered in this manner
suggests that this is the case. These findings underline the importance of co-localization
of antioxidants with potential sources of reactive oxygen species. Some previous studies
also indicate that zeaxanthin and/or lutein can exert protection in cultured ARPE-19 cells
against photo-oxidative damage, and that protection is more efficient if carotenoids are
co-localized with photosensitizers [47,115–117]. Wrona et al. have shown that zeaxanthin
supplemented by ARPE-19 cells exposed to visible light and merocyanine 540, a well-
characterized photosensitizer which associates with cell membranes, can substantially
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diminish oxidation of cholesterol but does not offer a significant protection against cyto-
toxicity unless it is given in combination with vitamin C or vitamin E and the exposure to
photo-oxidation is short [47]. In those studies, zeaxanthin was administered to ARPE-19
cells 24 h prior to exposure to the photosensitizer and light. In other studies, where the
photosensitizers were present inside the cells, such as phagocytosed lipofuscin, melano-
lipofuscin, or melanosomes, a combination of zeaxanthin with vitamin E were, at least
partly, preserving cell viability [115–117]. In these experiments, pigment granules were
enriched with antioxidants prior to administering to cultured cells. However, lutein and
zeaxanthin do not accumulate in substantial concentrations in the human RPE [34,35].
The photoreceptor outer segments are the main layers in the retina where lutein and
zeaxanthin are detected in substantial concentrations [34,35]. Potent photosensitizers can
transiently accumulate in these parts of neurons, and, upon absorption of light, generate
singlet oxygen [19–21,106]. In photoreceptor outer segments, all-trans-retinal is hydrolysed
from photoactivated visual pigments, and its clearance is dependent mainly on activities
of NADPH-dependent retinol dehydrogenase and the ATP-binding cassette transporter
rim protein (ABCR, also known as ABCA4) [19,21,36,55,56,118]. The loss of function
mutations in genes coding these enzymes result in delayed clearance of all-trans-retinal and
increased susceptibility to light-induced damage to the retina in the mouse. In the human
retina, mutations in the ABCA4 gene can lead to Stargardt’s disease, and are associated
with increased risk of a certain subtype of retinitis pigmentosa and age-related macular
degeneration. It is believed that photoexcitation of all-trans-retinal leads to the generation
of a singlet oxygen and initiates the damage. The photoreceptor outer segments are rich
in polyunsaturated fatty acids, such as docosahexaenoic acid, which are very susceptible
to oxidation by singlet oxygen and subsequent formation of lipid hydroperoxides. Lipid
hydroperoxides may themselves undergo decomposition in the presence of iron ions. Iron
ions are known to accumulate with age in the retina and that accumulation is increased
in age-related macular degeneration. Decomposition of lipid hydroperoxides generates
lipid peroxyl radicals, which can propagate lipid peroxidation, resulting in the formation
of end-products with photosensitizing properties [97]. Since these photosensitizing species
are not distributed uniformly and are likely to be localized in lipophilic structures, it is
important to determine to what extent carotenoids present in the photoreceptor outer
segments are free and localized in the lipid membranes or are bound to proteins in the
cytosolic environment. The localization of dehydrolutein present within the retina remains
incompletely investigated. Its presence in the lipid membrane would be significant given
its ability to function as a photoprotective agent.
This research addresses the role of non-pro-vitamin A carotenoids, especially the
hydroxyl carotenoids that function intact within the retina where they shield the retina from
oxidative damage that results from the activation of oxygen by blue light. The significance
is such that lutein and zeaxanthin are components of the AREDS2 formula. The AREDS
and AREDS2 clinical studies were separate 5-year studies carried out by the National
Eye Institute, USA, and were large randomized, multi-centre, double-masked, placebo-
controlled clinical trials, each recruiting >4000 AMD patients. These trials demonstrated
the benefits of an antioxidant supplement during the 5-year study periods [32,119]. More
recently, lutein and zeaxanthin have been identified within the brain and associated with
a cognitive benefit and are currently under further investigation as treatments to slow
the cognitive decline in aging and dementia [120–123]. As stated in the introduction,
increasing macular pigment density has been demonstrated to improve several aspects of
the visual function in addition to their photoprotection function [14,23–31]. Carotenoids
are unsurpassed singlet oxygen quenchers and accumulate in the retina in remarkably
high concentrations (>1 mM), thereby, having the potential to inhibit damage induced in
the retina by blue light-generated singlet oxygen. Understanding the high specificity and
selectivity of carotenoid uptake and accumulation mechanisms is essential for developing
and improving formulations that deliver these carotenoids efficiently to the retina. An
additional benefit of the study of carotenoids uptake and function in ARPE-19 cells is
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the potential that this research can provide novel insights into the delivery across the
retina/brain-blood barrier that may open avenues for the delivery of therapeutics to retinal
tissues and the treatment of a range of ocular pathologies.
5. Conclusions
In conclusion, our results demonstrate that dehydrolutein is a singlet oxygen quencher,
which is similarly effective in protecting from photooxidative damage as lutein or zeaxnthin.
Our findings point to the importance of determining whether dehydrolutein is present in
the retina as a free carotenoid in lipid membranes or bound to proteins. In order to elucidate
the role of RPE in selective carotenoid transport, further investigation of the mechanism
of transport should be undertaken. This information will provide insight and enable
further development of therapeutic strategies for increasing carotenoid accumulation in
lipid membranes of the RPE and photoreceptor outer segment membrane where they
are most needed as singlet oxygen quenchers and can most effectively protect against
light-induced injuries. These injuries can contribute to the development of age-related
macular degeneration and other diseases associated with increased (photo)oxidative stress
and/or lutein/zeaxanthin abnormalities, namely Stargardt’s disease, retinitis pigmentosa,
diabetic retinopathy, glaucoma, Sjögren-Larsson syndrome, and macular telangiectasia.
Author Contributions: Conceptualization, M.B.R. and J.T.L.; methodology, M.B.R., B.C.-P., J.T.L.
and B.R.; validation, M.B.R. and J.T.L.; formal analysis, M.B.R.; investigation, M.B.R., B.C.-P., J.T.L.
and B.R.; resources, M.B.R., B.C.-P., J.T.L. and B.R; data curation, M.B.R.; writing—original draft
preparation, M.B.R.; writing—review and editing, M.B.R., J.T.L. and B.R.; visualization, M.B.R.;
supervision, M.B.R.; project administration, M.B.R.; funding acquisition, M.B.R., J.T.L. and B.R. All
authors have read and agreed to the published version of the manuscript.
Funding: This research was funded by grants from the Ministry of Science and Higher Educa-
tion/State Committee for Scientific Research, Poland PB 6PO4A 06217 and 3P04A 044 23, and the
Travelling Wellcome Trust Fellowships to M.B.R. and B.R. Florida International University supplied
material support to J.T.L. This research was partly funded by the Wellcome Trust. For the purpose
of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted
Manuscript version arising from this submission.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: The numerical data presented in the manuscript are available upon
request from the corresponding author.
Acknowledgments: The authors acknowledge Howard Halpern, University of Chicago, IL, for the
generous gift of mHCTPO, Janusz Bigaj, University of Agriculture, Kraków, Poland, for processing
samples for TEM, and DSM Nutritional Products AG (Basel, Switzerland) for the generous gift of
lutein and zeaxanthin.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Bhosale, P.; Zhao, D.Y.; Bernstein, P.S. HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein
supplementation era. Investig. Ophthalmol. Vis. Sci. 2007, 48, 543–549. [CrossRef]
2. Khachik, F.; de Moura, F.F.; Chew, E.Y.; Douglass, L.W.; Ferris, F.L., 3rd; Kim, J.; Thompson, D.J. The effect of lutein and zeaxanthin
supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older. Investig. Ophthalmol. Vis. Sci. 2006,
47, 5234–5242. [CrossRef] [PubMed]
3. Khachik, F.; London, E.; de Moura, F.F.; Johnson, M.; Steidl, S.; Detolla, L.; Shipley, S.; Sanchez, R.; Chen, X.Q.; Flaws, J.; et al.
Chronic ingestion of (3R,3’R,6’R)-lutein and (3R,3’R)-zeaxanthin in the female rhesus macaque. Investig. Ophthalmol. Vis. Sci.
2006, 47, 5476–5486. [CrossRef] [PubMed]
4. Johnson, E.J.; Neuringer, M.; Russell, R.M.; Schalch, W.; Snodderly, D.M. Nutritional manipulation of primate retinas, III: Effects
of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Investig. Ophthalmol. Vis. Sci.
2005, 46, 692–702. [CrossRef]
Antioxidants 2021, 10, 753 21 of 25
5. Bhosale, P.; Bernstein, P.S. Quantitative measurement of 3’-oxolutein from human retina by normal-phase high-performance
liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry. Anal. Biochem. 2005, 345,
296–301. [CrossRef]
6. Thurmann, P.A.; Schalch, W.; Aebischer, J.C.; Tenter, U.; Cohn, W. Plasma kinetics of lutein, zeaxanthin, and 3-dehydro-lutein
after multiple oral doses of a lutein supplement. Am. J. Clin. Nutr. 2005, 82, 88–97. [CrossRef] [PubMed]
7. Hartmann, D.; Thurmann, P.A.; Spitzer, V.; Schalch, W.; Manner, B.; Cohn, W. Plasma kinetics of zeaxanthin and 3’-dehydro-lutein
after multiple oral doses of synthetic zeaxanthin. Am. J. Clin. Nutr. 2004, 79, 410–417. [CrossRef]
8. Khachik, F.; Bernstein, P.S.; Garland, D.L. Identification of lutein and zeaxanthin oxidation products in human and monkey
retinas. Investig. Ophthalmol. Vis. Sci. 1997, 38, 1802–1811.
9. Khachik, F.; Beecher, G.R.; Goli, M.B.; Lusby, W.R.; Smith, J.C., Jr. Separation and identification of carotenoids and their oxidation
products in the extracts of human plasma. Anal. Chem. 1992, 64, 2111–2122. [CrossRef] [PubMed]
10. Bernstein, P.S.; Khachik, F.; Carvalho, L.S.; Muir, G.J.; Zhao, D.Y.; Katz, N.B. Identification and quantitation of carotenoids and
their metabolites in the tissues of the human eye. Exp. Eye Res. 2001, 72, 215–223. [CrossRef] [PubMed]
11. Bone, R.A.; Landrum, J.T.; Tarsis, S.L. Preliminary identification of the human macular pigment. Vision Res. 1985, 25, 1531–1535.
[CrossRef]
12. Schalch, W.; Bone, R.A.; Landrum, J.T. The functional role of xanthophylls in the primate retina. In Carotenoids. Physical, Chemichal,
and Biological Functions and Properties; Landrum, J., Ed.; CRC Press: Boca Raton, FL, USA; London, UK; New York, NY, USA, 2010;
pp. 257–282.
13. Moran, N.E.; Mohn, E.S.; Hason, N.; Erdman, J.W., Jr.; Johnson, E.J. Intrinsic and extrinsic factors impacting absorption,
metabolism, and health effects of dietary carotenoids. Adv. Nutr. 2018, 9, 465–492. [CrossRef]
14. Widomska, J.; SanGiovanni, J.P.; Subczynski, W.K. Why is zeaxanthin the most concentrated xanthophyll in the central fovea?
Nutrients 2020, 12, 1333. [CrossRef] [PubMed]
15. Arunkumar, R.; Gorusupudi, A.; Bernstein, P.S. The macular carotenoids: A biochemical overview. Biochim. Biophys. Acta Mol.
Cell Biol. Lipids 2020, 1865. [CrossRef] [PubMed]
16. Krinsky, N.I.; Landrum, J.T.; Bone, R.A. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu. Rev.
Nutr. 2003, 23, 171–201. [CrossRef]
17. Edge, R.; Truscott, T.G. Singlet oxygen and free radical reactions of retinoids and carotenoids-A review. Antioxidants 2018, 7, 5.
[CrossRef]
18. Haralampus-Grynaviski, N.; Ransom, C.; Ye, T.; Rozanowska, M.; Wrona, M.; Sarna, T.; Simon, J.D. Photogeneration and
quenching of reactive oxygen species by urocanic acid. J. Am. Chem. Soc. 2002, 124, 3461–3468. [CrossRef]
19. Rozanowska, M.; Handzel, K.; Boulton, M.E.; Rozanowski, B. Cytotoxicity of all-trans-retinal increases upon photodegradation.
Photochem. Photobiol. 2012, 88, 1362–1372. [CrossRef] [PubMed]
20. Rozanowska, M.; Wessels, J.; Boulton, M.; Burke, J.M.; Rodgers, M.A.J.; Truscott, T.G.; Sarna, T. Blue light-induced singlet oxygen
generation by retinal lipofuscin in non-polar media. Free Radic. Biol. Med. 1998, 24, 1107–1112. [CrossRef]
21. Rozanowska, M.; Sarna, T. Light-induced damage to the retina: Role of rhodopsin chromophore revisited. Photochem. Photobiol.
2005, 81, 1305–1330. [CrossRef]
22. Boulton, M.; Rozanowska, M.; Rozanowski, B. Retinal photodamage. J. Photochem. Photobiol. B Biol. 2001, 64, 144–161. [CrossRef]
23. Bone, R.A.; Landrum, J.T.; Hime, G.W.; Cains, A.; Zamor, J. Stereochemistry of the human macular carotenoids. Investig.
Ophthalmol. Vis. Sci. 1993, 34, 2033–2040.
24. Li, B.X.; George, E.W.; Rognon, G.T.; Gorusupudi, A.; Ranganathan, A.; Chang, F.Y.; Shi, L.J.; Frederick, J.M.; Bernstein, P.S.
Imaging lutein and zeaxanthin in the human retina with confocal resonance Raman microscopy. Proc. Natl. Acad. Sci. USA 2020,
117, 12352–12358. [CrossRef]
25. Davey, P.G.; Henderson, T.; Lem, D.W.; Weis, R.; Amonoo-Monney, S.; Evans, D.W. Visual function and macular carotenoid
changes in eyes with retinal drusen-An open label randomized controlled trial to compare a micronized lipid-based carotenoid
liquid supplementation and AREDS-2 formula. Nutrients 2020, 12, 3271. [CrossRef] [PubMed]
26. Davey, P.G.; Lievens, C.; Ammono-Monney, S. Differences in macular pigment optical density across four ethnicities: A
comparative study. Ther. Adv. Ophthalmol. 2020, 12. [CrossRef] [PubMed]
27. Stringham, J.M.; O’Brien, K.J.; Stringham, N.T. Contrast sensitivity and lateral inhibition are enhanced with macular carotenoid
supplementation. Investig. Ophthalmol. Vis. Sci. 2017, 58, 2291–2295. [CrossRef] [PubMed]
28. Akuffo, K.O.; Beatty, S.; Peto, T.; Stack, J.; Stringham, J.; Kelly, D.; Leung, I.; Corcoran, L.; Nolan, J.M. The impact of supplemental
antioxidants on visual function in nonadvanced age-related macular degeneration: A head-to-head randomized clinical trial.
Investig. Ophthalmol. Vis. Sci. 2017, 58, 5347–5360. [CrossRef]
29. Bernstein, P.S.; Li, B.X.; Vachali, P.P.; Gorusupudi, A.; Shyam, R.; Henriksen, B.S.; Nolan, J.M. Lutein, zeaxanthin, and meso-
zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog.
Retin. Eye Res. 2016, 50, 34–66. [CrossRef] [PubMed]
30. Nolan, J.M.; Power, R.; Stringham, J.; Dennison, J.; Stack, J.; Kelly, D.; Moran, R.; Akuffo, K.O.; Corcoran, L.; Beatty, S. Enrichment
of macular pigment enhances contrast sensitivity in subjects free of retinal disease: Central Retinal Enrichment Supplementation
Trials—Report 1. Investig. Ophthalmol. Vis. Sci. 2016, 57, 3429–3439. [CrossRef]
Antioxidants 2021, 10, 753 22 of 25
31. Barker, F.M., 2nd; Snodderly, D.M.; Johnson, E.J.; Schalch, W.; Koepcke, W.; Gerss, J.; Neuringer, M. Nutritional manipulation of
primate retinas, V: Effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. Investig.
Ophthalmol. Vis. Sci. 2011, 52, 3934–3942. [CrossRef]
32. Age-Related Eye Disease Study 2 Research, G.; Chew, E.Y.; Clemons, T.E.; Sangiovanni, J.P.; Danis, R.P.; Ferris, F.L., 3rd; Elman,
M.J.; Antoszyk, A.N.; Ruby, A.J.; Orth, D.; et al. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular
degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol. 2014, 132, 142–149. [CrossRef]
33. Arunkumar, R.; Calvo, C.M.; Conrady, C.D.; Bernstein, P.S. What do we know about the macular pigment in AMD: The past, the
present, and the future. Eye 2018, 32, 992–1004. [CrossRef]
34. Sommerburg, O.G.; Siems, W.G.; Hurst, J.S.; Lewis, J.W.; Kliger, D.S.; van Kuijk, F.J. Lutein and zeaxanthin are associated with
photoreceptors in the human retina. Curr. Eye Res. 1999, 19, 491–495. [CrossRef]
35. Rapp, L.M.; Maple, S.S.; Choi, J.H. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and
peripheral human retina. Investig. Ophthalmol. Vis. Sci. 2000, 41, 1200–1209.
36. Maeda, T.; Golczak, M.; Maeda, A. Retinal photodamage mediated by all-trans-retinal. Photochem. Photobiol. 2012, 88, 1309–1319.
[CrossRef] [PubMed]
37. Edge, R.; Truscott, T.G. Properties of carotenoid radicals and excited states and their potential role in biological systems. In
Carotenoids. Physical, Chemical, and Biological Functions and Properties; Landrum, J.T., Ed.; CRC Press: Boca Raton, FL, USA; London,
UK; New York, NY, USA, 2010; pp. 283–308.
38. Bhosale, P.; Zhao, D.Y.; Serban, B.; Bernstein, P.S. Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid
metabolite in the human macula. Investig. Ophthalmol. Vis. Sci. 2007, 48, 1435–1440. [CrossRef]
39. Molnar, P.; Deli, J.; Osz, E.; Toth, G.; Zsila, F.; Herrero, C.; Landrum, J.T. Preparation and spectroscopic characterization of
3’-oxolutein. Lett. Org. Chem. 2006, 3, 723–734. [CrossRef]
40. Vakrat-Haglili, Y.; Weiner, L.; Brumfeld, V.; Brandis, A.; Salomon, Y.; McIlroy, B.; Wilson, B.C.; Pawlak, A.; Rozanowska, M.; Sarna,
T.; et al. The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J. Am. Chem. Soc.
2005, 127, 6487–6497. [CrossRef] [PubMed]
41. Wrona, M.; Korytowski, W.; Rozanowska, M.; Sarna, T.; Truscott, T.G. Cooperation of antioxidants in protection against
photosensitized oxidation. Free Radic. Biol. Med. 2003, 35, 1319–1329. [CrossRef]
42. Szoka, F., Jr.; Papahadjopoulos, D. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu. Rev.
Biophys. Bioeng. 1980, 9, 467–508. [CrossRef] [PubMed]
43. Halpern, H.J.; Peric, M.; Nguyen, T.D.; Spencer, D.P.; Teicher, B.A.; Lin, Y.J.; Bowman, M.K. Selective isotopic labeling of a
nitroxide spin label to enhance sensitivity for T2 oxymetry. J. Magn. Reson. 1990, 90, 40–51. [CrossRef]
44. Rozanowska, M.; Jarvis-Evans, J.; Korytowski, W.; Boulton, M.E.; Burke, J.M.; Sarna, T. Blue light-induced reactivity of retinal age
pigment. In vitro generation of oxygen-reactive species. J. Biol. Chem. 1995, 270, 18825–18830. [CrossRef] [PubMed]
45. Dunn, K.C.; Aotaki-Keen, A.E.; Putkey, F.R.; Hjelmeland, L.M. ARPE-19, a human retinal pigment epithelial cell line with
differentiated properties. Exp. Eye Res. 1996, 62, 155–169. [CrossRef] [PubMed]
46. Rozanowska, M.; Bakker, L.; Boulton, M.E.; Rozanowski, B. Concentration dependence of vitamin C in combinations with vitamin
E and zeaxanthin on light-induced toxicity to retinal pigment epithelial cells. Photochem. Photobiol. 2012, 88, 1408–1417. [CrossRef]
47. Wrona, M.; Rozanowska, M.; Sarna, T. Zeaxanthin in combination with ascorbic acid or alpha-tocopherol protects ARPE-19 cells
against photosensitized peroxidation of lipids. Free Radic. Biol. Med. 2004, 36, 1094–1101. [CrossRef]
48. Rozanowska, M.; Korytowski, W.; Rozanowski, B.; Skumatz, C.; Boulton, M.E.; Burke, J.M.; Sarna, T. Photoreactivity of aged
human RPE melanosomes: A comparison with lipofuscin. Investig. Ophthalmol. Vis. Sci. 2002, 43, 2088–2096.
49. Rozanowska, M.; Pawlak, A.; Rozanowski, B.; Skumatz, C.; Zareba, M.; Boulton, M.E.; Burke, J.M.; Sarna, T.; Simon, J.D.
Age-related changes in the photoreactivity of retinal lipofuscin granules: Role of chloroform-insoluble components. Investig.
Ophthalmol. Vis. Sci. 2004, 45, 1052–1060. [CrossRef]
50. Rozanowski, B.; Burke, J.; Sarna, T.; Rozanowska, M. The pro-oxidant effects of interactions of ascorbate with photoexcited
melanin fade away with aging of the retina. Photochem. Photobiol. 2008, 84, 658–670. [CrossRef]
51. Rozanowski, B.; Burke, J.M.; Boulton, M.E.; Sarna, T.; Rozanowska, M. Human RPE melanosomes protect from photosensitized
and iron-mediated oxidation but become pro-oxidant in the presence of iron upon photodegradation. Investig. Ophthalmol. Vis.
Sci. 2008, 49, 2838–2847. [CrossRef]
52. Rozanowski, B.; Cuenco, J.; Davies, S.; Shamsi, F.A.; Zadlo, A.; Dayhaw-Barker, P.; Rozanowska, M.; Sarna, T.; Boulton, M.E. The
phototoxicity of aged human retinal melanosomes. Photochem. Photobiol. 2008, 84, 650–657. [CrossRef]
53. Miodonski, A.J.; Bigaj, J.; Plytycz, B. Light and electron-microscopic observations on the thymic capillaries and postcapillary
venules in Rana temporaria L. Folia Histochem. Cytobiol. 1994, 32, 91–100. [PubMed]
54. Redmond, R.W.; Kochevar, I.E. Medical applications of rose Bengal- and riboflavin-photosensitized protein crosslinking. Pho-
tochem. Photobiol. 2019, 95, 1097–1115. [CrossRef] [PubMed]
55. Maeda, A.; Maeda, T.; Golczak, M.; Palczewski, K. Retinopathy in mice induced by disrupted all-trans-retinal clearance. J. Biol.
Chem. 2008, 283, 26684–26693. [CrossRef]
56. Kiser, P.D.; Golczak, M.; Palczewski, K. Chemistry of the retinoid (visual) cycle. Chem. Rev. 2014, 114, 194–232. [CrossRef]
[PubMed]
Antioxidants 2021, 10, 753 23 of 25
57. During, A.; Doraiswamy, S.; Harrison, E.H. Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells
via a SRBI-dependent mechanism. J. Lipid Res. 2008, 49, 1715–1724. [CrossRef] [PubMed]
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